Espranor 2mg oral lyophilisates
BNF presentation 0410030A0BFAAAL within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0410030A0BFAAAL
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
7,443
NHS spend (£)
£173,555.12
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 534 |
| February 2025 | 127 |
| December 2024 | 528 |
| November 2024 | 835 |
| October 2024 | 988 |
| September 2024 | 2 |
| August 2024 | 162 |
| July 2024 | 849 |
| June 2024 | 103 |
| May 2024 | 596 |
| July 2021 | 502 |
| June 2021 | 549 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 274 | No data available |
| Unknown pharmacy | 227 | No data available |
| Unknown pharmacy | 219 | No data available |
| Unknown pharmacy | 207 | No data available |
| Unknown pharmacy | 192 | No data available |
| Unknown pharmacy | 192 | No data available |
| Unknown pharmacy | 157 | No data available |
| Unknown pharmacy | 142 | No data available |
| Unknown pharmacy | 122 | No data available |
| Unknown pharmacy | 116 | No data available |